Vaginal sling market seen reaching $2.48 billion by 2030

The Business Research Company says the vaginal sling market will grow from $1.75 billion in 2026 to $2.48 billion by 2030, powered by rising stress urinary incontinence, aging female populations and more minimally invasive procedures. North America led in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - The vaginal sling market is tied to treatment for stress urinary incontinence, a condition affecting a growing number of women as populations age. - The forecast points to sustained demand for outpatient, minimally invasive and implant-based gynecological procedures through 2030. - More information

What happened: - The Business Research Company projected the vaginal sling market will rise from $1.6 billion in 2025 to $1.75 billion in 2026. - The market is forecast to reach $2.48 billion by 2030. - The report puts the market’s 2025-2026 CAGR at 9.5% and the 2026-2030 CAGR at 9.1%.

The details: - Vaginal slings are mesh implants used to reinforce ligaments and connective tissues that support urinary control. - The devices are commonly used to treat stress urinary incontinence and help reduce leakage. - Growth drivers include more cases of stress urinary incontinence, more gynecological surgeries, expansion of hospital-based urogynecology services and wider awareness of surgical solutions. - The report also cites standardization of sling products as a growth factor. - Future growth is expected to come from more outpatient incontinence procedures, greater focus on patient safety and biocompatibility, broader female healthcare services, more minimally invasive gynecological surgeries and higher healthcare spending on women’s health. - Key trends include more use of minimally invasive sling techniques, preference for synthetic and lightweight mesh materials, rising interest in adjustable sling systems, expansion of outpatient treatment options and stronger focus on long-term implant safety. - In 2025, North America held the largest share of the market. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report’s 2026 edition adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables. - Download a free sample

Between the lines: - The growth story is being shaped by demographics as much as by surgical innovation. - The aging female population, especially women 65 and older, is a central demand driver because urinary dysfunction becomes more common in that group. - Statistics Netherlands reported in January 2023 that the female population aged 90 and above was substantially larger than the male population, underscoring the long-term aging trend behind the market. - The regional split suggests mature demand in North America and faster adoption potential in Asia-Pacific as healthcare access expands.

What's next: - The market’s next phase appears to be centered on safety, biocompatibility and less invasive care pathways. - Report buyers can access more detail through the company’s sample and full-report links. - The Business Research Company also provided contact information for expert inquiries and media follow-up. - The company’s LinkedIn page